Inogen (INGN) Cash & Current Investments (2012 - 2026)
Inogen's (INGN) quarterly Cash & Current Investments came in at $105.5 million in Q2 2026, down 13.8% year-over-year from $122.4 million in Q2 2025, and down 4.2% quarter-over-quarter from $110.2 million in Q1 2026.
Analysis
Inogen (INGN) Cash & Current Investments (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Cash & Current Investments for 15 consecutive years, with $105.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 13.8% year-over-year to $105.5 million in Q2 2026; TTM through Jun 2026 was $105.5 million, a 13.8% decrease from a year earlier, with the FY2025 full-year figure at $119.6 million, down 1.2% from the prior year.
- Cash & Current Investments was $105.5 million for Q2 2026 at Inogen, down from $110.2 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $223.6 million in Q2 2022 and troughed at $105.5 million in Q2 2026.
- A 5-year average of $149.3 million and a median of $122.9 million in 2025 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments tumbled 37.62% in 2023 and rose 4.03% in 2025, its largest moves.
- Over 5 years, Cash & Current Investments stood at $206.0 million in 2022, then plunged by 37.62% to $128.5 million in 2023, then fell by 5.79% to $121.0 million in 2024, then dropped by 1.2% to $119.6 million in 2025, then decreased by 11.74% to $105.5 million in 2026.
- The last three Cash & Current Investments figures came in at $105.5 million (Q2 2026), $110.2 million (Q1 2026), and $119.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 105.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.54 Mn |
| Mar 31, 2026 | 110.17 Mn |
| Dec 31, 2025 | 119.58 Mn |
| Sep 30, 2025 | 123.22 Mn |
| Jun 30, 2025 | 122.43 Mn |
| Mar 31, 2025 | 122.54 Mn |
| Dec 31, 2024 | 121.04 Mn |
| Sep 30, 2024 | 120.66 Mn |
| Jun 30, 2024 | 117.69 Mn |
| Mar 31, 2024 | 119.81 Mn |
| Dec 31, 2023 | 128.47 Mn |
| Sep 30, 2023 | 138.04 Mn |
| Jun 30, 2023 | 187.61 Mn |
| Mar 31, 2023 | 179.06 Mn |
| Dec 31, 2022 | 205.95 Mn |
| Sep 30, 2022 | 218.11 Mn |
| Jun 30, 2022 | 223.62 Mn |
| Mar 31, 2022 | 223.39 Mn |
| Dec 31, 2021 | 245.51 Mn |
| Sep 30, 2021 | 245.13 Mn |